Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Cancer (Mcrc)”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Testing effectiveness (Phase 2)UnknownNCT04247256
What this trial is testing

Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Who this might be right for
Metastatic Colorectal Cancer
Scandion Oncology A/S 35
Not applicableUnknownNCT01754272
What this trial is testing

A Non-Interventional Follow-Up to the VELOUR Study - Translational Research

Who this might be right for
Metastatic Colorectal Cancer
KU Leuven 1,226
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Large-scale testing (Phase 3)Looking for participantsNCT06134388
What this trial is testing

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Tanta University 50
Large-scale testing (Phase 3)Study completedNCT01931150
What this trial is testing

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Who this might be right for
Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveMetastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 11
Large-scale testing (Phase 3)Looking for participantsNCT05768503
What this trial is testing

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Who this might be right for
Metastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University 176
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446387
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502014
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)mCRC
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Looking for participantsNCT07255664
What this trial is testing

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Who this might be right for
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
CuraCell TX AB 12
Testing effectiveness (Phase 2)Looking for participantsNCT07012954
What this trial is testing

CtDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 64
Large-scale testing (Phase 3)Looking for participantsNCT03303495
What this trial is testing

2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisIntestinal Neoplasms+2 more
Sun Yat-sen University 280
Testing effectiveness (Phase 2)Ended earlyNCT04952753
What this trial is testing

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 204
Testing effectiveness (Phase 2)Study completedNCT02651415
What this trial is testing

Phase II Study of Perindopril and Regorafenib in mCRC

Who this might be right for
Metastatic Colorectal Cancer
British Columbia Cancer Agency 12
Early research (Phase 1)Study completedNCT01966289
What this trial is testing

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Early research (Phase 1)Not Yet RecruitingNCT07566897
What this trial is testing

A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors

Who this might be right for
Renal Carcinoma MetastaticPancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma+1 more
Philogen S.p.A. 96
Testing effectiveness (Phase 2)UnknownNCT03567629
What this trial is testing

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

Who this might be right for
mCRC
Peking University 130
Testing effectiveness (Phase 2)Study completedNCT01478594
What this trial is testing

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

Who this might be right for
Colorectal Cancer
AVEO Pharmaceuticals, Inc. 265
Not applicableUnknownNCT04656782
What this trial is testing

EORTC-endorsed, Prospective European Multicenter Imaging Survey and Protocol

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 40
Testing effectiveness (Phase 2)Ended earlyNCT00755118
What this trial is testing

Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Who this might be right for
Colorectal Cancer
University Hospital of Crete 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07071844
What this trial is testing

BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 162
Next Page